Spironolactone (Aldactone, CaroSpir) and Black patients
Brand names: Aldactone, CaroSpir
What Spironolactone does
Spironolactone blocks the effect of aldosterone, a hormone that tells the kidney to retain sodium and excrete potassium. Blocking it lowers blood pressure and helps the heart and kidneys in people with heart failure or resistant hypertension. It also blocks testosterone receptors, which is why it's used for acne and for hirsutism in PCOS.
What the evidence says for Black patients
Spironolactone has a disproportionately important role in Black patients with resistant hypertension, defined as blood pressure above goal on three drugs at near-maximal doses. The PATHWAY-2 trial (Williams et al., Lancet 2015;386:2059–68, PMID 26414968) found spironolactone superior to bisoprolol and doxazosin as a fourth-line agent, with the mean systolic-BP reduction exceeding 8 mm Hg. Black adults have disproportionately high rates of resistant hypertension and of the aldosterone-driven physiology that spironolactone addresses.
In heart failure, the RALES trial (Pitt et al., NEJM 1999;341:709–17) established spironolactone's mortality benefit in HFrEF. Subsequent analyses showed similar effects across racial groups.
Spironolactone is also a mainstay of PCOS-associated hirsutism and of moderate-to-severe hormonal acne. Both conditions disproportionately affect Black women, and spironolactone's hyperpigmentation-neutral profile makes it preferable to oral tetracyclines (which can worsen skin discoloration).
Common alternatives
Eplerenone is a more selective aldosterone antagonist with fewer sex-hormone side effects (less gynecomastia, no menstrual irregularity) but it is more expensive and less potent per milligram. Amiloride is an alternative potassium-sparing diuretic that does not block testosterone receptors.
Side effects
- Hyperkalemia — the most important safety issue. Risk is higher in CKD, in combination with ACE inhibitors or ARBs, and in older adults. Regular potassium monitoring is mandatory.
- Gynecomastia (breast enlargement/tenderness in men)
- Menstrual irregularities in women
- Decreased libido, erectile dysfunction
- Acute kidney injury, especially if dehydrated
Factors that affect adherence
Gynecomastia is the single biggest driver of discontinuation. Patients should be warned about it explicitly; many will switch to eplerenone. Potassium labs require follow-up visits, which can be a barrier — consider pairing a potassium check with an already-scheduled visit rather than a separate trip.
Questions to ask your doctor
Bring this list to your next appointment.
- If I'm Black and my BP is resistant, should I be on spironolactone?
- How often will we check my potassium?
- If I develop breast tenderness, can I switch to eplerenone?
- Is this safe with my ACE inhibitor or ARB?
References
- Williams B, MacDonald TM, Morant S, et al. Spironolactone versus placebo, bisoprolol, and doxazosin in resistant hypertension (PATHWAY-2). Lancet. 2015;386:2059–2068. PMID 26414968.
- Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). NEJM. 1999;341:709–717. PMID 10471456.
- Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: detection, evaluation, and management. A scientific statement from the AHA. Hypertension. 2018;72:e53–e90.
- U.S. Food and Drug Administration. Aldactone (spironolactone) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012151s083lbl.pdf
Medical disclaimer
This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.
Read our editorial standards for how we source, review, and update these pages.